Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03AOP
|
||||
Former ID |
DNCL003435
|
||||
Drug Name |
DS-8500
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Phase 2 | [524885] | ||
Company |
Daiichi Sankyo
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Modulator | [544477] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.